Cite
HARVARD Citation
Wick, A. et al. (2020). Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma. Neuro-oncology. 22 (8), pp. 1162-1172. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wick, A. et al. (2020). Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma. Neuro-oncology. 22 (8), pp. 1162-1172. [Online].